am going to do some DD on morphoSys this week. I want to find out more about the milestones and royalties. This indication is a mega market, and if bapineuzumab fails, but looks promising in mild AD, this could be a great investment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.